Literature DB >> 7752576

Tyrosine kinase activity of the EGF receptor in murine metanephric organ culture.

J L Pugh1, W E Sweeney, E D Avner.   

Abstract

Epidermal growth factor (EGF) and its fetal form, transforming growth factor alpha (TGF-alpha) are renal mitogens which induce epithelial hyperplasia, proximal tubular cyst formation (TC), and accelerated distal nephron differentiation in metanephric organ culture. To delineate the intracellular mechanisms mediating these growth factor effects, we studied the specific role of the epidermal growth factor receptor (EGF-R), the common receptor for both ligands, as an activated tyrosine kinase in TC formation and nephrogenesis. Fetal murine metanephric explants were incubated for 120 hours in control, and EGF (15 ng/ml)/TGF-alpha (10 ng/ml) supplemented medium with and without EGF-R blocking monoclonal antibody (50 mg/ml), or tyrosine kinase inhibitor. EGF-R tyrosine kinase inhibition was achieved by incubation with a synthetic tyrphostin (TP B42) (0.1 microM) or genestein (5.5 micrograms/ml). The following parameters were assessed: (a) segment-specific nephron development using morphometry and immunohistology; (b) tubular epithelial hyperplasia by protein content and BrdU uptake; and (c) TC formation by morphometric cystic index. Both growth factors produced hyperplastic proximal TC, significantly increased explant growth, and significantly increased distal nephron differentiation. Inhibiting the ligand-EGF-R interaction with EGF-R blocking monoclonal antibody abolished all growth factor-induced effects and resulted in increased amounts of undifferentiated mesenchyme and decreased distal nephron differentiation. Inhibition of EGF-R tyrosine kinase activity with either Tyrphostin B42 or genestein blocked TC formation and produced nodular blastemal hyperplasia and decreased distal nephron differentiation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7752576     DOI: 10.1038/ki.1995.118

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  9 in total

Review 1.  Signal transduction in podocytes--spotlight on receptor tyrosine kinases.

Authors:  Jochen Reiser; Sanja Sever; Christian Faul
Journal:  Nat Rev Nephrol       Date:  2014-01-07       Impact factor: 28.314

2.  Epidermal growth factor receptor activity mediates renal cyst formation in polycystic kidney disease.

Authors:  W G Richards; W E Sweeney; B K Yoder; J E Wilkinson; R P Woychik; E D Avner
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

3.  The role of hepatocyte growth factor (HGF) at progressive stages of metanephric development.

Authors:  W E Sweeney; E D Avner
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-02       Impact factor: 2.416

4.  Transforming growth factor alpha and epidermal growth factor expression in experimental murine polycystic kidney disease.

Authors:  M R Ogborn; S Sareen
Journal:  Pediatr Nephrol       Date:  1996-04       Impact factor: 3.714

5.  Epidermal growth factor-induced proliferation of collecting duct cells from Oak Ridge polycystic kidney mice involves activation of Na+/H+ exchanger.

Authors:  Sonya D Coaxum; Mary G Blanton; Alisha Joyner; Tanjina Akter; P Darwin Bell; Louis M Luttrell; John R Raymond; Mi-Hye Lee; Paul A Blichmann; Maria N Garnovskaya; Takamitsu Saigusa
Journal:  Am J Physiol Cell Physiol       Date:  2014-07-23       Impact factor: 4.249

6.  Epidermal growth factor activates Na(+/)H(+) exchanger in podocytes through a mechanism that involves Janus kinase and calmodulin.

Authors:  Sonya D Coaxum; Maria N Garnovskaya; Monika Gooz; Aleksander Baldys; John R Raymond
Journal:  Biochim Biophys Acta       Date:  2009-03-31

7.  Urinary EGF Receptor Ligand Excretion in Patients with Autosomal Dominant Polycystic Kidney Disease and Response to Tolvaptan.

Authors:  Laura R Harskamp; Ron T Gansevoort; Wendy E Boertien; Wim van Oeveren; Gerwin E Engels; Harry van Goor; Esther Meijer
Journal:  Clin J Am Soc Nephrol       Date:  2015-07-31       Impact factor: 8.237

Review 8.  The epidermal growth factor receptor pathway in chronic kidney diseases.

Authors:  Laura R Harskamp; Ron T Gansevoort; Harry van Goor; Esther Meijer
Journal:  Nat Rev Nephrol       Date:  2016-07-04       Impact factor: 28.314

Review 9.  Emerging Therapies for Childhood Polycystic Kidney Disease.

Authors:  William E Sweeney; Ellis D Avner
Journal:  Front Pediatr       Date:  2017-04-19       Impact factor: 3.418

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.